1h Free Analyst Time
The Germany pharmaceuticals market is forecasted to grow by USD 21.44 bn during 2022-2027, accelerating at a CAGR of 6.25% during the forecast period. The report on the Germany pharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in the pharmaceutical industry, the increasing geriatric population, and the growing number of M and A.
The Germany pharmaceuticals market is segmented as below:
By Distribution Channel
- Pharmacy
- Clinic
By Type
- Prescription
- Non-prescription
The report on the Germany pharmaceuticals market covers the following areas:
- Germany pharmaceuticals market sizing
- Germany pharmaceuticals market forecast
- Germany pharmaceuticals market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
Exhibits:
Executive Summary
The publisher recognizes the following companies as the key players in the Germany pharmaceuticals market: Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson Services Inc., MCM Klosterfrau Vertriebsgesellschaft mbH, Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi, STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the robust growth of e-commerce.'
According to the report, one of the major drivers for this market is the high investment in the pharmaceutical industry.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol Myers Squibb
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Fresenius SE and Co. KGaA
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- MCM Klosterfrau Vertriebsgesellschaft mbH
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi
- STADA Arzneimittel AG
- Teva Pharmaceutical Industries Ltd.